INNERCOOL to test catheter for fever control:
This article was originally published in Clinica
INNERCOOL therapies is to begin a clinical study of its endovascular cooling catheter in patients who develop a fever after suffering a haemorrhagic stroke. The Celsius Control system, which induces, maintains and/or reverses hypothermia to prevent tissue damage during periods of ischaemia, will be assessed by researchers at the Massachusetts General Hospital in Boston. The San Diego, California firm also announced that it has added 10 more clinical investigation sites to an ongoing US trial that is evaluating use of the device during the surgical repair of unruptured brain aneurysms.
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.